Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1(2-butyl-5-nitrobenzofuran-3-yl)(4-hydroxyphenyl)methanone

02 1(2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile

03 1(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihhyrdro[1,2,4] triazolo [4,3-a] pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl) butan-2-one

04 1(3R,4R)-1-Benzyl-N,4-dimethyl-3-piperidinamine dihydrochloride

05 11-(2-Chloroethyl)-piperidine hydrochloride

06 11-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole

07 11-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole Hydrochloride

08 11-(3-Pyridyl)-3-(dimethylamino)-2-propen-1-one

09 11-(3-iodo-1-isopropyl-1H-pyrazol-4-yl)ethanone

10 11-chloro-4-methoxybutane

11 12,3-Dibromobutane-1,4-diol

12 12-(2-Ethoxyphenoxy)ethyl Methanesulfonate

13 12-(2-Ethoxyphenoxy)ethyl bromide

14 12-(4-Bromo-phenyl)-2-methyl-propionic acid

15 12-(piperidin-4-yl)-1H-benzo[d]imidazole

16 12-Chloro-5-hydroxypyridine

17 12-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate

18 12-[4-(2-chloro-ethyl)-phenyl]-2-methyl-propionic acid methyl ester

19 12-[4-[1-(4,4-dimethyl-5H-oxazol-2yl)-1-methyl-ethyl]phenyl]ethyl 4-methylbenzenesulfonate

20 12-allyl-3-methoxybenzaldehyde

21 12-butyl-3-[4-(3-dibutylaminopropoxy)benzoyl]-5-nitrobenzofura

22 12-ethoxyethyl-4-methylbenzenesulfonate

23 12-n-Butyl-5-nitrobenzofuran

24 13'-Bromoacetophenone

25 13,5-Dichloro salicylaldehyde

26 13-(2-Chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one

27 13-Acetylpyridine

28 13-Amino-4-methylpyridine

29 13-Methylflavone -8-Carboxylic Acid

30 13-amino-1-Adamantanol

31 14-((4-methylpiperazin-1-yl)methyl)benzoic acid dihydrochloride

32 14-(1-Hydroxy-1-methylethyl)-2-propyl-1H-imidazole-5-carboxylic Acid Ethyl Ester)

33 14-(trifluoromethyl)benzonitrile

34 14-Bromopyridine hydrochloride

35 14-Methyl-3-[4-(3-pyridyl)pyrimidin-2-ylamino]aniline

36 14-Nitropyrazole

37 15-Amino-2-chloropyridine

38 15-Amino-4,6-dichloro-2-(propylthio)pyrimidine

39 15-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone

40 25-Nitrosalicylaldehyde

41 15-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate

42 15-[(2R)-2-Aminopropyl]-2,3-dihydro-1-[3-(phenylmethoxy)propyl]-1H-indole-7-carbonitrile

43 1Bromoacetaldehyde diethyl acetal

44 1Butadiene diepoxide

45 1Chloro-7H-pyrrolo[2,3-d]pyrimidine

46 1R-(-)-5-(2-Amino-propyl)-2-methoxy-benzenesulfonamide

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
141645-16-1
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyd...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank
207557-35-5
Vildagliptin
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyd...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank

02

AMWC Asia-TDAC
Not Confirmed
arrow
AMWC Asia-TDAC
Not Confirmed
arrow

Ocimum Labs

(2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile

CAS Number : 207557-35-5

End Use API : Vildagliptin

About the Company : Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm fo...

blank
764667-65-4
Sitagliptin Phosphate
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyd...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank
1062580-52-2
Tofacitinib Citrate
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyd...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank
2008-75-5
Flavoxate
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyd...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank

05

AMWC Asia-TDAC
Not Confirmed
arrow
AMWC Asia-TDAC
Not Confirmed
arrow

Ocimum Labs

1-(2-Chloroethyl)-piperidine hydrochloride

CAS Number : 2008-75-5

End Use API : Flavoxate

About the Company : Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm fo...

blank
110963-63-8
Bilastine
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyd...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank

06

AMWC Asia-TDAC
Not Confirmed
arrow
1841081-72-8
Bilastine
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyd...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank
1269440-49-4
Encorafenib
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyd...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank

08

AMWC Asia-TDAC
Not Confirmed
arrow
AMWC Asia-TDAC
Not Confirmed
arrow

Ocimum Labs

1-(3-iodo-1-isopropyl-1H-pyrazol-4-yl)ethanone

CAS Number : 1269440-49-4

End Use API : Encorafenib

About the Company : Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm fo...

blank
55314-16-4
Imatinib Mesylate
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyd...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank

09

AMWC Asia-TDAC
Not Confirmed
arrow
17913-18-7
Fluvoxamine
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyd...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank

10

AMWC Asia-TDAC
Not Confirmed
arrow
AMWC Asia-TDAC
Not Confirmed
arrow

Ocimum Labs

1-chloro-4-methoxybutane

CAS Number : 17913-18-7

End Use API : Fluvoxamine

About the Company : Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm fo...

blank
Contact Ocimum Labs and get a quotation

Ocimum Labs is a supplier offers 4 products (APIs, Excipients or Intermediates).

Find Bilastine bulk offered by Ocimum Labs

Find Flavoxate bulk offered by Ocimum Labs

Find Lurasidone Hydrochloride bulk offered by Ocimum Labs

Find Ticagrelor bulk offered by Ocimum Labs